Back to search results

Botulinum Toxin for Involuntary Movement Disorders

This study is looking at how botulinum toxin (BTX) is used to treat people with movement disorders, which are conditions that cause involuntary muscle spasms or movements. Researchers are observing how these disorders progress over time and how people respond to standard BTX injections. The study also helps train doctors on how to properly use BTX for these conditions. You might be able to join if you are 2 years or older and have a movement disorder that your doctor thinks could be helped by BTX, such as dystonia or tremor. The goal is to understand the natural course of movement disorders and how BTX treatment works for them.

Study design
This is an observational study, meaning researchers are watching and collecting information without giving a specific treatment for the study. It aims to include up to 2000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants are followed for the 'Study Natural History' and to 'Maintain cohort of subjects', both measured as ongoing.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00001208

Botulinum Toxin for the Treatment of Involuntary Movement Disorders

Recruiting
Not specifiedAges 2+Observational
National Institute of Neurological Disorders and Stroke (NINDS)
~2,000 participants
Updated 2026-08-28 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Study Natural History- data analysis
Measured over Ongoing
+1 more outcome measured

Conditions

Movement Disorders

Explore related trials

BlepharospasmDystoniaHemifacial spasmMovement DisorderOral Lingual DyskinesiaSpastic dysphoniaSpasticityTardive dyskinesiaTic disorderTremorVocal Fold Tremor

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Debra J Ehrlich, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Neurological Disorders and Stroke (NINDS)

Who to contact

Vivian S Koo
[email protected]
(301) 435-8518
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Study Natural History- data analysisOngoing

    Data regarding the movement disorder of the subject and observations of their standard treatment will be collected. Data may be used for future research questions that are related to subjects movement disorder and/or treatment.

  • Maintain cohort of subjectsOngoing

    To maintain a cohort of patients with dystonia and other movement disorders for participation in other studies on the physiology of dystonia and BTX injection